Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Classical hematology 2Plasma cell 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 78Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia 69Lymphoma, Non-Hodgkin 68Multiple Myeloma 64Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Large B-Cell, Diffuse 61Myelodysplastic Syndromes 59Lymphoma, Follicular 59Hodgkin Disease 58Lymphoma, Mantle-Cell 52Lymphoma, Large-Cell, Immunoblastic 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 41Leukemia, Myeloid, Chronic-Phase 40Leukemia, Myeloid, Accelerated Phase 40Congenital Abnormalities 39Neoplasms, Plasma Cell 37Myeloproliferative Disorders 37Leukemia, Myelomonocytic, Chronic 31Waldenstrom Macroglobulinemia 29Recurrence 29Blast Crisis 29Primary Myelofibrosis 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Anemia, Refractory, with Excess of Blasts 21Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 20Dendritic Cell Sarcoma, Interdigitating 20Lymphoma, Large-Cell, Anaplastic 19

Interventions

fludarabine phosphate 4Cyclophosphamide 4Busulfan 3Antilymphocyte Serum 3fludarabine 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2thymoglobulin 1sargramostim 1prexasertib 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy 1Quercetin 1Mycophenolic Acid 1Melphalan 1Dietary Supplements 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Fanconi Anemia × Peripheral Blood Stem Cell Transplantation × Clear all
NCT02143830 2025-11-12

RAFA

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
70 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Fanconi Anemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00053989 2020-02-10

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Roswell Park Cancer Institute

Phase 2 Completed
41 enrolled 13 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Fanconi Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡